« Back
Home /
Remetinostat

Remetinostat

Manufacturer	MedChem Express
Category	Reagents & Chemicals Biochemicals
Type	Chemicals
Specific against	other
Amount	25 mg
Item no.	HY-100365-25mg
CASRN	946150-57-8
eClass 6.1	32160000
eClass 9.0	32160000
Available
Alias	SHP-141
Purity	98.0
Product Description	Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma[1].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	323.34
Clinical_Information	Phase 2
Manufacturers Research_Area	Cancer
Solubility	DMSO : 150 mg/mL (ultrasonic)
Manufacturers Target	HDAC
Pathway	Cell Cycle/DNA Damage; Epigenetics
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Request delivery time